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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   
 














JAMA | Brief 
Report 
 Case series of 4 previously 
healthy children with 
neurological symptoms 
caused by inflammatory 
syndrome associated with 
COVID-19.  
 Two recovered, the other 
two improving but still in 
hospital and currently 
wheelchair bound due to 
muscle weakness.  
 Children with C19 may 
present with new 
neurological symptoms in 
























 Uses data on COVID-19 
deaths by age for 26 
countries 
 Data and analysis for 
estimating potential burden 
in different countries 
 On average, the age-
mortality curve is flatter in 
developing countries. In rich 
countries, people ages 70-
79 are 12.6 times as likely to 
die as those ages 50-59. In 
the LMICs, this ratio is 3.5. 
 This pattern holds 
separately for men’s and 
women’s mortality rates 
 Authors discuss possibilities 

















 BMJ | 
Research 
 Sensitivity and 
specificity, stratified by 
method of serological 
testing, are reported 
 Sensitivity was higher 
at least 3 weeks after 
symptom onset 
compared with the first 
week 
 Authors call for higher 
quality clinical studies 
assessing the diagnostic 
accuracy of serological 
tests for C19 
 Available evidence  does 
not support the continued 





















 PLOS | ONE 
 Fieldwork in two 
villages in central Sierra 
Leone suggest that 
rural people in SL retain 
the lessons of 
experience from the 
Ebola outbreak of 2014-
15 
 Authors expect that 
rural populations will be 
able to apply these 
lessons to the C19 
context reducing the 





Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article type Author(s) 
July 2020 Tackling antimicrobial resistance in the 
COVID-19 pandemic 
Bull WHO | Editorial  
02.07.2020 UN enlists 10,000 digital volunteers to 
fight COVID-19 misinformation 
Devex | News  
01.07.2020 Accelerating development of SARS-CoV-
2 vaccines – the role for controlled human 
infection models 





et al.  
01.07.2020 Do-It-Yourself pandemic: it’s time for 
accountability in models 
Issues in Science 





30.06.2020 All bets are off for measuring pandemic 
preparedness 










29.06.2020 No clinical benefit from use of lopinavir-
ritonavir in hospitalised COVID-19 
patients studied in RECOVERY 
RECOVERY Trial | 
News 
 
29.06.2020 Timeline of WHO’s response to COVID-
19 
WHO | News  
28.06.2020 The hard nut of cracking who is 
vulnerable in our communities in the 
context of COVID-19 
Arise |Blog Joseph 
Kimani 
26.06.2020 COVID-19 research in brief: December, 
2019 to June, 2020 
Nature | News  
25.06.2020 Ensuring continuity of tuberculosis care 
during the covid-19 crisis 









COVID-19 vaccine development and 
access virtual conference 
Africa CD| News  
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  Sierra 
Leone 





US NIH  Our World 
in Data: C19 
Testing 




Our World in 
Data 






      
Global 5050 









  US  COVID-19 
Primer 





     NIH 
LitCovid 
 UKCDR       
Information 
is Beautiful 
     WHO 
COVID-19 
Database 
        
LSHTM               
HealthMap 
(cases) 




              
C19 Resource Hubs 









  Social 
Sciences 
WHO COVID-
19 pandemic  
Africa CDC Annals of 
Internal 
Medicine 
LSTM Stop TB 
Partnership 
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Institute of Public 
Health 
    





Oxford Centre for 
Evidence-based 
Medicine 
    




 HEART     
UNESCO   NEJM  UKRI     
UN WFP   Oxford 
University 
Press 
 Evidence Aid     
GOARN   PLoS  NIH     
EPI-WIN   SAGE 
journals 
IFPRI Resources 
and Analyses of 
C19 Impact 
    
8 
World Bank   Science  Prevent 
Epidemics  
    
Our World in 
Data 
  Springer 
Nature 




  SSRN 
(Preprints)  
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Online learning & events 








treatment of severe 
COVID-19  






mitigating the collateral 
effects of COVID-19 
Online event 1h 30 CGD 
13 July 




Lecture: Global Health 
Preparedness by Dr 
Muhammad Pate, 
Global Director for 
Health, Nutrition and 








UCL, The Lancet 
June 2020 OpenWHO, the free, 
open-access learning 
platform for health 
emergencies, now 
offers 10 online 







Africa’s leadership role 
in COVID-19 vaccine 
development and 
access 












Nursing in Times of 
Crisis 
Online course 2 weeks – 2 
hours per 
week 




WHO Academy and 
WHO Info mobile 
applications 




Modelling and Policy 
Online 
learning 













Webinar 1 hour WHO & ISQua – Dr 
Shams Syed, Dr 
Peter Lachman, Dr 
Teri Rynolds & Dr Ed 
Kelley 




5 hours Johns Hopkins 




Virtual Evidence Weeks 5 sessions 1h 30 International Initiative 











COVID-19 Open online 
brief with Dr David 
Nabarro 
Event 1h 4SD 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 






COVID-19: methods for 
detection, prevention, 
response and control 
Online 
learning 




19: Real-time training 

















































Edinburgh & Royal 
College of Physicians 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
© DFID - Crown copyright 2020. 
 
